Objective-To determine the diagnostic efficiency of oral contrast-enhanced gastric ultrasonography in the evaluation of gastric lesions, based on large-scale multicenter study.
poor performance have been barriers to populationbased gastric cancer screening.
In the last decades, oral contrast-enhanced gastric ultrasonography has gained importance as a noninvasive, well-tolerated, and widely accessible imaging modality in the diagnosis and follow up of gastric lesions, allowing clear visualization of the involved gastric segments and adjacent structures. [1] [2] [3] Moreover, Chinese researchers developed several oral contrast agents to improve the assessment of the gastrointestinal tract and adjacent structures by pushing, absorbing, and displacing gastrointestinal contents and gas, which provide an excellent acoustic window for sonographic visualization of the gastrointestinal tract. Two of these oral contrast agents, Tianxia V R (Dongya Pharmaceuticals Co, Huzhou, China) and Xinzhang V R (Huqingyutang Pharmaceuticals Co, Hangzhou, China) were developed and commercially available in China for ultrasound imaging of the gastrointestinal tract in clinical settings. [4] [5] [6] [7] [8] [9] [10] [11] However, a multicenter study on the reliability of oral contrast-enhanced gastric ultrasonography based on a large sample has not been reported. The purpose of our study, therefore, was to determine the diagnostic efficiency of oral contrast-enhanced gastric ultrasonography in the evaluation of gastric lesions.
Patients and Methods
Protocol of the Study Each patient was initially submitted to a standardized clinical interview and physical examination by a gastroenterologist who did not take part in the imaging procedures. Each patient underwent conventional ultrasonography and oral contrast-enhanced ultrasonography in the same day as the first diagnostic procedure. Upper gastrointestinal endoscopy was subsequently performed on the following days. All patients were independently evaluated with conventional and contrast enhanced ultrasonography by two sonographers who had an experience exceeding 2000 sonographic examinations of the stomach. All patients were also independently evaluated with upper gastrointestinal endoscopy by two digestive endoscopy experts who had an experience exceeding 2000 endoscopic examinations of the stomach.
Study Population
Between July 2008 and February 2016, 383,945 consecutive patients with suspect gastric lesions were enrolled in this study. They all had undergone complete oral contrastenhanced gastric ultrasonography and endoscopic evaluation. All final diagnoses were confirmed by surgical pathological findings. There were 194,331 males and 189,614 females, aged from 3 days to 89 years with a mean age of 55.7 6 12.6 years. Our hospital's ethical committee approved this study, and all patients gave informed consent and agreed to participate. For participating children, informed consent was obtained from their parents.
Equipment and Contrast Agents
Several types of full digital ultrasound scanners: ATL HDI 5000 or iU22 (Philips Medical Systems, Bothell, WA) with a C5-2 Convex probe; Aloka Prosound 3500, 5000, 5500, a10 with a UST convex probe (Aloka, Tokyo, Japan); and Sequoia-512, Acuson S2000 or S3000 (Siemens Medical Solutions, Mountain View, CA) with a 4C1 probe were used in this study.
The commercially available oral contrast agent Tianxia V R (Dongya Pharmaceuticals Co, Huzhou, China) was supplied as powder, derived form coix seed, yam, and pericarpium citri reticulatae. The 50g package was reconstituted by adding 400 to 500 mL of boiled water brought to room temperature and gently agitating it by hand to form a homogeneous thin paste.
Conventional Ultrasonography
All patients were examined after an overnight fast of at least 8 hours, but without any special preparation. The stomachs were then carefully scanned using real-time, gray-scale imaging. The scanning parameters (eg, the depth, focus, and gain) were adjusted to achieve optimal imaging display. The vertical, horizontal, and oblique scans were performed along the body surface projection of the stomach in the upper abdomen. The structural hierarchy and thickness of the gastric wall; the continuity and integrity of each layer; the location, shape, and size of any possible lesions (localized thickening or uplift, localized burst or concave, localized interruption); the layer involved; the stomach peristalsis; and adjacent structures were all carefully imaged and recorded under dynamic scanning with patients in the supine and both of the decubitus positions.
Oral Contrast-Enhanced Gastric Ultrasonography Immediately after conventional ultrasonography, the patient was invited to drink the oral contrast agent (400500 ml for adults, 30100 ml for infants). During the consumption, a real-time ultrasonography was carefully performed. Vertical, horizontal, and oblique scans were again performed along the body surface projection of the stomach in the upper abdomen, and seven standardized views (the esophagus bottom cardia junction, gastric bottom, gastric body, gastric coronary oblique view, gastric angle, gastric antrum, and pyloric duodenal junction) were obtained ( Figure 1 ). The homogeneity Figure 1 . Seven standardized views of oral contrast-enhanced gastric ultrasonography. A, The esophagus bottom cardia junction; B, gastric bottom; C, gastric body; D, gastric coronary oblique view; E, gastric angle (triangle); F, gastric antrum; G, high frequency ultrasonography showing three layers of normal gastric antrum wall; H, pyloric duodenal junction (arrow, pylorus).
and clarity of the oral contrast agent distribution; the structural hierarchy and thickness of the gastric wall; the continuity and integrity of each layer; the location, shape and size of any possible lesions (localized thickening or uplift, localized burst or concave, localized interruption, ie, the contrast filling defect or niche); the layer involved; the stomach peristalsis; and the adjacent structures were carefully imaged and recorded again under dynamic scanning with patients in the supine and both of the decubitus positions. The scanning parameters (eg, the depth, focus, and gain) were adjusted to achieve optimal imaging display as conventional ultrasound examination.
Upper Gastrointestinal Endoscopy
All patients underwent upper gastrointestinal endoscopy by experienced endoscopists. They fasted at least 8 hours on the day after having an oral contrast-enhanced gastric ultrasonography. All endoscopic examination procedures were performed on an Olympus V 70, GIF-H260, GIF-XP260 or a GIF-Q180 device (Olympus, Tokyo, Japan), and a Pentax EPK-100 device (HOYA, Tokyo, Japan). With patients in the left decubitus position with their head bent slightly forward, the endoscope was gently inserted into the subject's throat after it was numbed with an oral lidocaine lozenge (Kangye Pharmaceuticals Co, Handan, P.R. China). During the procedure, the endoscope was slowly moved and the walls of esophagus, stomach, and duodenum were carefully checked and any possible lesions (localized thickening or uplift, localized burst or concave) were photographed and, when necessary, biopsied.
Management
In order to ensure the accuracy of this study, a standardized protocol (including clinical interview, physical examination, conventional ultrasonography, oral contrast-enhanced ultrasonography, upper gastrointestinal endoscopy, surgical pathology, and statistical analysis) was carefully followed. At the same time, we built a unified sbase. In each site the data were managed and collected by two statisticians. To verify the accuracy of data transmission, all the statisticians from the multiple sites checked the data individually and made necessary corrections bimonthly. In each study, after discussion, the agreed upon results from the two sonographers were reported. When the readers disagreed, another experienced sonographer was invited to opine until a consensus was reached between two of the three experienced sonographers (ie, when the readers disagreed, the valuesizes, numbers, present or absent at the site, present or absent minor mucosal/submucosal abnormalities, and the adjacent structures abnormalities-confirmed by the third experienced sonographer was chosen). However, for this instance, there was agreement between the initial two readers every time.
Statistical Analysis
A Kappa test was used to estimate the inter observer agreement and the agreement between the two types of ultrasonography. The upper gastrointestinal endoscopy was used to identify the sites, sizes, numbers, adjacent structures, and the extent of gastric lesions. The sensitivity and specificity was calculated to obtain the accuracy of oral contrast-enhanced gastric ultrasonography in detecting gastric lesions. Sensitivity was defined as the proportion of patients with detection at ultrasonography, divided by the patients with gastric lesions as final diagnosis. Specificity was defined as the proportion of patients with a negative detection at ultrasonography, divided by the patients without gastric lesions as final diagnosis. A Pearson's correlation analysis was used to assess the correlation between the ultrasonography examination and surgical pathological findings in detecting gastric lesion extents. In this study surgical pathological findings were used as the gold standard and upper gastrointestinal endoscopic findings were used as a comparison. A P value of less than .05 was considered statistically significant and SPSS 13.0 (SPSS Inc, Chicago, IL) was used for statistical analysis.
Results

Variety of Gastric Lesions
A satisfactory gastric distension to permit a complete gastric examination was obtained in all patients after oral administration of the contrast. No major complaints were reported during this procedure.
In the study, there were 103,568 cases with benign lesions, including gastric ulcer (n 5 45338) (Figure 2 ), duodenal bulbar ulcer (n 5 48909), gastric polyps (n 5 899), gastric stromal tumors (n 5 6327), congenital hypertrophic pyloric stenosis (n 5 256), gastric heterotopic pancreas (n 5 952), gastric cyst (n 5 133), gastric stones (n 5 132), gastric varices (n 5 398), and gastric mucosa prolapse (n 5 224). There were 46,952 cases with malignant lesions, including gastric cancer (n 5 28497) (Figure 3 ), cardia carcinoma (n 5 13367), gastric malignant lymphoma (n 5 4265), and gastric remnant carcinoma (n 5 823).
Detection of the Sites, and Extent of Gastric Lesions at Conventional Contrast-Enhanced Ultrasonography and Upper Gastrointestinal Endoscopy
Using surgical pathological findings as gold standard, the sensitivities, specificities, positive predictive values (PPV), negative predictive values (NPV), and accuracies of oral contrast-enhanced ultrasonography in detecting the lesions at any site of the stomach (including the esophagus bottom cardia junction, pyloric duodenal junction, gastric bottom, gastric body, gastric angle, and gastric antrum) were far greater than conventional ultrasonography (P < .01). Morever, there was no significant difference between oral contrast-enhanced ultrasonography and upper gastrointestinal endoscopy in detecting the gastric lesions at the sites mentioned above according to the sensitivity, specificity, positive and negative predictive value (PPV and NPV), and accuracy (P > .05) ( Table 1) .
In order to establish the three techniques' (conventional ultrasonography, oral contrast-enhanced ultrasonography, and upper gastrointestinal endoscopy) ability to assess disease-extent within the stomach, a correlation between the extent of gastric carcinoma measured with the three techniques and the extent determined by surgical pathology was made. Conventional ultrasonography measurement correlated well with surgical involvement (r 5 .71), but measurements made at contrast-enhanced ultrasonography and upper gastrointestinal endoscopy proved to be even more accurate (r 5 .95, r 5 .97, respectively) (P < .05) (Figure 4) . Indeed, the extent of gastric carcinoma as evaluated by the latter two techniques was quite similar to that measured at surgical pathology (9.0 6 1.7 vs. 9.1 6 1.8cm 3 , P > .05; 9.0 6 1.6 vs. 9.1 6 1.8cm 3 , P > .05, respectively). Moreover, overall agreement (k) between surgical pathological findings, conventional ultrasonography, oral contrastenhanced ultrasonography, and upper gastrointestinal endoscopy in detecting gastric lesion sites were .74 (CI .64 to .83), .92 (CI .88 to .95), and .93 (CI .87 to .99), respectively. In addition, the agreement (k) between Figure 2 . Oral contrast-enhanced ultrasound imaging of a small gastric ulceration. A, Gastric ulceration lesion appeared as a contrast agent-filled defect on the wall of the lesser curvature of stomach with a spot-like mural hyperechogenic area. B, The surgical specimen demonstrated the gastric ulceration lesion (the area within white line) which consistent to the oral contrast-enhanced ultrasonography findings. C, The pathological changes of gastric ulcer (necrotic layer, the exudate and the necrotic cellular debris; inflammation layer, mainly neutrophils; fresh granulation tissue; scar tissue layer) (magnification, 3 200) was seen and coincident with the oral contrast-enhanced ultrasound imaging.
oral contrast-enhanced ultrasonography and upper gastrointestinal endoscopy in identifying the sites of gastric lesions was .98 (CI .97 to .99). Table 2 , using surgical pathological findings as gold standard, oral contrast-enhanced ultrasonography was far better than conventional ultrasonography in detection of a single gastric lesion and multiple gastric lesions (P < .01), and had the same ability as upper gastrointestinal endoscopy in detecting the number of gastric lesions identified at surgical pathology, according to the sensitivity, specificity, PPV, NPV, and accuracy (P > .05). The agreement (k) between oral contrastenhanced ultrasonography and upper gastrointestinal endoscopy in identifying the numbers of gastric lesions was .97 (CI .96 to .99). Table 3 . It is worth noting that oral contrast-enhanced ultrasonography was far better than conventional ultrasonography (P < .01) and had the same ability as upper gastrointestinal endoscopy in detecting the small gastric lesions (<5mm) as identified at surgical pathology (P > .05). The agreement (k) between oral contrastenhanced ultrasonography and upper gastrointestinal endoscopy in identifying the small gastric lesions (<5mm) was .92 (CI .87 to .96).
Detection of Single
Gastric Lesion and Multiple Gastric Lesions (>2) at Conventional, ContrastEnhanced Ultrasonography, and Upper Gastrointestinal Endoscopy As shown in
Detection of the Small Gastric Lesions
However, oral contrast-enhanced ultrasonography performed poorer than upper gastrointestinal endoscopy Figure 3 . Oral contrast-enhanced ultrasound imaging of an early gastric carcinoma. A, The characteristics of this gastric carcinoma were demonstrated with oral contrast ultrasound imaging, including irregular shape, homogeneous echotexture, protruding into the cavity, and disrupted mucosal and submucosal layers of the gastric wall. B, The surgical specimen demonstrated the gastric carcinoma lesion (the area within white line) which consistent to the oral contrast-enhanced ultrasonography findings. C, The pathological changes of an early gastric carcinoma involving to mucosal and submucosal layers of the gastric wall was seen and coincident with the oral contrast-enhanced ultrasound imaging (magnification, 3200).
(accuracy, 73.6% vs. 94.7%, P < .05), which also performed better than conventional ultrasonography (accuracy, 73.6% vs. 25.6%, P < .01), in detecting the minor mucosal abnormalities (<5mm). It is conceivable that oral contrast-enhanced ultrasonography was far better than upper gastrointestinal endoscopy (accuracy, 94.8% vs. 8.0%, P < .05), and was better than conventional ultrasonography (accuracy, 94.8% vs. 48.4%, P < .01) in detecting the submucosal abnormalities (<5mm), as identified at surgical pathology. The agreement (k) between oral contrast-enhanced ultrasonography and upper gastrointestinal endoscopy in identifying the minor mucosal abnormalities was .66 (CI .54 to .78), and submucosal abnormalities were .23 (CI .15 to .33).
Detection of the Adjacent Structures Abnormalities at Conventional, Contrast-Enhanced Ultrasonography and Upper Gastrointestinal Endoscopy
A comparison between conventional ultrasonography, oral contrast-enhanced ultrasonography, and upper gastrointestinal endoscopy in revealing the adjacent structures abnormalities of the involved gastric segments (such as gastric wall outside invasion, lymph node metastasis, and liver metastasis) determined by surgical pathology is reported in Table 4 . We can see that oral contrastenhanced ultrasonography was far better than upper gastrointestinal endoscopy (P < .01), and was slightly better than conventional ultrasonography (P < .05) in detecting the adjacent structures abnormalities as identified at surgical pathology according to the sensitivity, specificity, PPV, NPV, and accuracy. The agreement (k) between oral contrast-enhanced ultrasonography and upper gastrointestinal endoscopy was .17 (CI .13 to .22), and it was .95 (CI .88 to .97) between oral contrast-enhanced ultrasonography and conventional ultrasonography in identifying adjacent structures abnormalities.
Interobserver Agreement at Conventional Ultrasonography, and Oral Contrast-Enhanced Ultrasonography, and Upper Gastrointestinal Endoscopy As shown in Table 5 , with the exception of the adjacent structures abnormalities of the involved gastric segments, interobserver agreement (k) at conventional ultrasonography were from .22 to .51, and with the exception of 
Discussion
This is the first study on the reliability of oral contrastenhanced gastric ultrasonography based on a large-scale multicenter study. The results presented here indicate that oral contrast-enhanced gastric ultrasonography is superior to conventional gastric ultrasonography in defining anatomic location and extension of a variety of gastric lesions. Its diagnostic performance is not worse than upper gastrointestinal endoscopy. In China, the gastrointestinal endoscopy is always implemented in patients already showing obvious symptoms of gastric lesions. Being that the endoscopy is often performed too late, the results are often a diagnosis of gastric cancer. The lack of a comfortable, reliable approach that is widely accepted by patients in identifying the gastric lesions partly accounts for this result. Ultrasonography has attracted more attention in the last few decades due to its convenience, comfort, and safety. As early as in 1978, ultrasonography was used by Warren et al 12 to image stomach and duodenum, via a liquidfilled ultrasonic window. Since then, a series of similar studies was also conducted in China. 1, [4] [5] [6] [7] [8] [9] [10] [11] Recently, however, oral contrast-enhanced gastric ultrasonography is gaining in popularity. This is thanks to the presence of two kinds of oral contrast agents, Tianxia V R and Xinzhang V R . They are homogeneous thin pastes that provide an excellent acoustic window; they have a pleasant fragrance, are long lasting, and require a small quantity. They also have no side effects, and are easily accepted by patients, especially children and the elderly.
A lot of domestic and international small sample research indicates that oral contrast-enhanced ultrasonography is a reliable means to evaluate the gastrointestinal lesions. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] To date, however, no prospective large sample (>10,000) multicenter study, based on standardization of the procedure, has specifically compared this technique to conventional ultrasonography and upper gastrointestinal endoscopy against the reference of surgical pathology. Moreover, the potential ability of this procedure to improve the chance for a common consensus between sonographers on the sites, sizes, numbers, minor mucosal/submucosal abnormalities, adjacent structures, and extent of gastric lesions by reducing air artifacts and favoring dissociation (thus visualization) remains to be fully determined. In this study, we demonstrated that oral contrast imaging could provide an excellent acoustic window for evaluation of a variety of gastric lesions by conventional grayscale imaging. Furthermore, oral contrast imaging serves as an important platform for the assessment of blood perfusion characteristics of the Our results show that oral contrast-enhanced ultrasonography was more accurate than conventional ultrasonography in detecting the sites, sizes, numbers, and extensions of gastric lesions, and provided almost similar results as upper gastrointestinal endoscopy in detecting small gastric lesions. Moreover, oral contrast-enhanced ultrasonography was more accurate than upper gastrointestinal endoscopy in detecting submucosal abnormalities and the adjacent structure abnormalities of the involved gastric segments. However, it is worth mentioning that upper gastrointestinal endoscopy is still superior to oral contrast-enhanced ultrasonography, and is far superior to conventional ultrasonography in identifying minor mucosal abnormalities. These comparisons were not reported in other research.
Further, it is very important to have agreement between interobservers for oral contrast-enhanced ultrasonography and our study showed that there is significant improvement (an average K value of .4) in agreement between sonographers post oral contrast. As far as the tolerability and duration of the examination on the whole, these are highly satisfactory in comparison with upper gastrointestinal endoscopy. After standardization of the procedure, the mean duration of the whole examination is somewhat less than 5 minutes, as the post contrast phase can be started 1 minute after oral administration and completed approximately 3 minutes later. The procedure may occasionally take more time to be completed under specific circumstances, such as in the presence of complex lesions, where a careful evaluation of the entire stomach and duodenum is required in order to correctly localize their site, degree, and extension.
Our study has some possible advantages, such as a prospective study design, a large number of cases with various gastric abnormalities, and a blinded comparison with endoscopic examinations using surgical pathological findings as gold standard. Despite the efforts of the standardization of methods, it is hard to avoid the differences among different research institutions. This is a possible limitation of this study. In addition, acute and chronic gastritis cases were not included because the surgical pathology results were difficult to obtain, therefore, further research is still needed. In conclusion, this is the first prospective multicenter study on the reliability of oral contrast-enhanced gastric ultrasonography based on a large sample. Our study indicates that oral contrast-enhanced gastric ultrasonography is superior to conventional gastric ultrasonography in defining anatomic location and extension of a variety of gastric lesions. Its diagnostic performance is not worse than upper gastrointestinal endoscopy, and it can be used as a useful supplement to upper gastrointestinal endoscopy. Thanks to the lack of radiation exposure, availability, repeatability, and low cost, this technique should therefore be regarded as the first imaging procedure in the diagnostic work up, and follow up, of gastric lesions, especially for gastric cancer screening.
